Use of semaglutide linked to doubled risk of neovascular macular degeneration - Medical Xpress
12.06.2025 12:55

Semaglutide, widely used to treat diabetes and obesity, was associated with more than double the risk of developing neovascular age-related macular degeneration (nAMD) in older patients with diabetes… [+3834 chars]